Hide
First once-daily nonstimulant to be approved for use alone or in combination with stimulants for treatment of ADHD
PHILADELPHIA, Feb. 28, 2011 /PRNewswire/ — Shire plc, (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company
Read More...
Read the complete post at http://kiddieyap.com/2011/02/fda-approves-intuniv®-guanfacine-extended-release-tablets-for-use-as-adjunctive-therapy-to-stimulants-for-the-treatment-of-adhd-in-children-and-adolescents/
Posted
Feb 28 2011, 01:13 AM
by
Kiddie Yaps